These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23149942)

  • 41. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
    Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
    BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance.
    Satoh M; Andoh Y; Clingan CS; Ogura H; Fujii S; Eshima K; Nakayama T; Taniguchi M; Hirata N; Ishimori N; Tsutsui H; Onoé K; Iwabuchi K
    PLoS One; 2012; 7(2):e30568. PubMed ID: 22383967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD1d-dependent endogenous and exogenous lipid antigen presentation.
    McEwen-Smith RM; Salio M; Cerundolo V
    Curr Opin Immunol; 2015 Jun; 34():116-25. PubMed ID: 25805574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutation of the Traj18 gene segment using TALENs to generate Natural Killer T cell deficient mice.
    Zhang J; Bedel R; Krovi SH; Tuttle KD; Zhang B; Gross J; Gapin L; Matsuda JL
    Sci Rep; 2016 Jun; 6():27375. PubMed ID: 27256918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
    Guan P; Schaub R; Nichols KE; Das R
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of Invariant Natural Killer T Cells Redirects the Inflammatory Response in Neonatal Sepsis.
    Bolognese AC; Yang WL; Hansen LW; Sharma A; Nicastro JM; Coppa GF; Wang P
    Front Immunol; 2018; 9():833. PubMed ID: 29720984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.
    Liu J; Gallo RM; Khan MA; Iyer AK; Kratzke IM; Brutkiewicz RR
    Eur J Immunol; 2019 Feb; 49(2):255-265. PubMed ID: 30467836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigen-dependent versus -independent activation of invariant NKT cells during infection.
    Holzapfel KL; Tyznik AJ; Kronenberg M; Hogquist KA
    J Immunol; 2014 Jun; 192(12):5490-8. PubMed ID: 24813205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional education of invariant NKT cells by dendritic cell tuning of SHP-1.
    Napolitano A; Pittoni P; Beaudoin L; Lehuen A; Voehringer D; MacDonald HR; Dellabona P; Casorati G
    J Immunol; 2013 Apr; 190(7):3299-308. PubMed ID: 23427253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor.
    Humeniuk P; Geiselhart S; Battin C; Webb T; Steinberger P; Paster W; Hoffmann-Sommergruber K
    Sci Rep; 2019 May; 9(1):7426. PubMed ID: 31092850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.
    Tsaih SW; Presa M; Khaja S; Ciecko AE; Serreze DV; Chen YG
    Genes Immun; 2015; 16(3):221-30. PubMed ID: 25654212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis.
    Olson CM; Bates TC; Izadi H; Radolf JD; Huber SA; Boyson JE; Anguita J
    J Immunol; 2009 Mar; 182(6):3728-34. PubMed ID: 19265151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE.
    Liu F; Fan H; Ren D; Dong G; Hu E; Ji J; Hou Y
    Eur J Immunol; 2015 Jul; 45(7):1934-45. PubMed ID: 25929465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NKT-cell help to B lymphocytes can occur independently of cognate interaction.
    Tonti E; Galli G; Malzone C; Abrignani S; Casorati G; Dellabona P
    Blood; 2009 Jan; 113(2):370-6. PubMed ID: 18832653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probiotics alleviate adipose inflammation in high-fat diet-induced obesity by restoring adipose invariant natural killer T cells.
    Wang X; Ba T; Cheng Y; Zhang P; Chang X
    Nutrition; 2021 Sep; 89():111285. PubMed ID: 34116395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
    Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
    Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.
    Yang JQ; Wen X; Kim PJ; Singh RR
    J Immunol; 2011 Feb; 186(3):1512-20. PubMed ID: 21209282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.